Journal Article: Utility of Triazole Antifungal Therapeutic Drug Monitoring: Insights from the Society of Infectious Diseases Pharmacists - Infectious Disease Connect Journal Article: Utility of Triazole Antifungal Therapeutic Drug Monitoring: Insights from the Society of Infectious Diseases Pharmacists - Infectious Disease Connect

Academic Literature

Journal Article: Utility of Triazole Antifungal Therapeutic Drug Monitoring: Insights from the Society of Infectious Diseases Pharmacists

ID Connect’s clinical consultant Erin McCreary, PharmD, and Matt Davis, PharmD, Director of Infectious Diseases Pharmacy Services, along with their colleagues from the Society of Infectious Diseases Pharmacists (SIDP), published a landmark peer-reviewed journal article on triazole antifungals, which are commonly used in clinical practice to treat fungal infections. On behalf of SIDP, this insight describes the pharmacokinetic principles and pharmacodynamic targets of commonly used triazole antifungals and provides the rationale for utility of TDM within each agent.


You might also like…

Podcast – Navigating Infectious Disease with Dr. Rima Abdel Massih 

Journal Article – Things We Do for No Reason – Ordering Streptococcus pneumoniae Urinary Antigen in Patients with Community-Acquired Pneumonia 

Nupur Gupta, DO, MPH, Sheds Light on Rural Infectious Diseases Care Challenges in Exclusive Healio Feature

Receive Your Copy of IDC’s Information

Please fill out the form below to access this content.

Thank you, the form submit was successful!